CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 64 filers reported holding CUE BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $446,250 | +25.3% | 125,000 | 0.0% | 0.06% | -17.4% |
| Q4 2022 | $356,250 | -20.1% | 125,000 | -37.5% | 0.07% | -45.7% |
| Q3 2022 | $446,000 | +79.1% | 200,000 | +100.0% | 0.13% | +56.8% |
| Q2 2022 | $249,000 | -82.9% | 100,000 | -20.0% | 0.08% | -86.6% |
| Q2 2021 | $1,456,000 | +19.3% | 125,000 | +25.0% | 0.61% | +19.1% |
| Q1 2021 | $1,220,000 | -55.8% | 100,000 | -54.7% | 0.51% | -63.5% |
| Q4 2020 | $2,761,000 | -19.0% | 220,714 | -2.6% | 1.39% | -28.4% |
| Q3 2020 | $3,410,000 | +225.1% | 226,573 | +429.4% | 1.94% | +177.5% |
| Q2 2020 | $1,049,000 | +40.1% | 42,800 | -51.7% | 0.70% | -30.0% |
| Q1 2020 | $749,000 | -49.0% | 88,670 | -4.1% | 1.00% | +352.9% |
| Q4 2019 | $1,469,000 | – | 92,500 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |